TY - JOUR T1 - Effect of postextubation noninvasive ventilation with active humidification vs high-flow nasal cannula on reintubation in patients at very high risk for extubation failure: a randomized trial. AU - Hernández,Gonzalo, AU - Paredes,Irene, AU - Moran,Francisco, AU - Buj,Marcos, AU - Colinas,Laura, AU - Rodríguez,María Luisa, AU - Velasco,Alfonso, AU - Rodríguez,Patricia, AU - Pérez-Pedrero,María José, AU - Suarez-Sipmann,Fernando, AU - Canabal,Alfonso, AU - Cuena,Rafael, AU - Blanch,Lluis, AU - Roca,Oriol, Y1 - 2022/11/18/ PY - 2022/07/06/received PY - 2022/10/16/accepted PY - 2022/11/19/pubmed PY - 2022/12/1/medline PY - 2022/11/18/entrez KW - Active humidification KW - High-flow nasal cannula KW - Noninvasive ventilation KW - Outcome KW - Reintubation KW - Weaning SP - 1751 EP - 1759 JF - Intensive care medicine JO - Intensive Care Med VL - 48 IS - 12 N2 - PURPOSE: High-flow nasal cannula (HFNC) oxygen therapy was noninferior to noninvasive ventilation (NIV) for preventing reintubation in a heterogeneous population at high-risk for extubation failure. However, outcomes might differ in certain subgroups of patients. Thus, we aimed to determine whether NIV with active humidification is superior to HFNC in preventing reintubation in patients with ≥ 4 risk factors (very high risk for extubation failure). METHODS: Randomized controlled trial in two intensive care units in Spain (June 2020‒June 2021). Patients ready for planned extubation with ≥ 4 of the following risk factors for reintubation were included: age > 65 years, Acute Physiology and Chronic Health Evaluation II score > 12 on extubation day, body mass index > 30, inadequate secretions management, difficult or prolonged weaning, ≥ 2 comorbidities, acute heart failure indicating mechanical ventilation, moderate-to-severe chronic obstructive pulmonary disease, airway patency problems, prolonged mechanical ventilation, or hypercapnia on finishing the spontaneous breathing trial. Patients were randomized to undergo NIV with active humidification or HFNC for 48 h after extubation. The primary outcome was reintubation rate within 7 days after extubation. Secondary outcomes included postextubation respiratory failure, respiratory infection, sepsis, multiorgan failure, length of stay, mortality, adverse events, and time to reintubation. RESULTS: Of 182 patients (mean age, 60 [standard deviation (SD), 15] years; 117 [64%] men), 92 received NIV and 90 HFNC. Reintubation was required in 21 (23.3%) patients receiving NIV vs 35 (38.8%) of those receiving HFNC (difference -15.5%; 95% confidence interval (CI) -28.3 to -1%). Hospital length of stay was lower in those patients treated with NIV (20 [12‒36.7] days vs 26.5 [15‒45] days, difference 6.5 [95%CI 0.5-21.1]). No additional differences in the other secondary outcomes were observed. CONCLUSIONS: Among adult critically ill patients at very high-risk for extubation failure, NIV with active humidification was superior to HFNC for preventing reintubation. SN - 1432-1238 UR - https://www.unboundmedicine.com/medline/citation/36400984/Effect_of_postextubation_noninvasive_ventilation_with_active_humidification_vs_high_flow_nasal_cannula_on_reintubation_in_patients_at_very_high_risk_for_extubation_failure:_a_randomized_trial_ DB - PRIME DP - Unbound Medicine ER -